Abstract:Abstract Objective:To explore the efficacy of nerve block in the treatment of Herpes zoster neuralgia neuralgia (HZN).Methods:A total of 153 HZN patients who received nerve block therapy in the pain Department of Jinling Hospital affiliated to Medical College of Nanjing University from June 2018 to June 2022 were analyzed retrospectively.According to the course of herpes zoster, they were divided into acute group (Acute Herpetic Neuralgia, AHN) (1 ~ 30 days), subacute group (subacute herpetic neuralgia, SHN)(31 ~ 90 days) and chronic group (Postherpetic Neuralgia, PHN) (more than 91 days). All patients were treated with nerve block twice with an interval of 7 days.The visual analogue score (Visual Analogue Scale, VAS), oral drug dosage, Pittsburgh sleep quality index (Pittsburgh SleepQuality Index, PSQI), patient satisfaction score (Likert scale) and adverse reactions were recorded before admission, at discharge, 1 month and 3 months after discharge.Results:The scores of patients in the three groups at discharge were significantly better than those at admission (P < 0.05). The dosage of pregabalin in AHN group and SHN group at 1 month and 3 months was lower than that at discharge. The dosage of opioids in AHN group was significantly lower than that at admission and discharge (P < 0.001). 30% of patients in AHN group stopped taking drugs completely within 3 months after discharge. The scores of VAS, PQSI and Likert in AHN group were significantly better than those in SHN group and PHN group, and the incidence of adverse drug reactions was lower.Conclusion:The earlier the patients with HZN are treated with nerve block, the higher the effective rate of pain relief is, the longer the pain relief is, and the shorter the course of oral medication is, which has a certain preventive effect on the occurrence of PHN.